Targeting Lipids to Improve Outcomes in Your Cath Patients-Genetic Basis of Lipoprotein (a), ApoB, and Lipid Analysis in Contemporary Practice

Genetic Basis of Lipoprotein (a), ApoB, and Lipid Analysis in Contemporary Practice

Video Transcription

Video Summary

The talk focuses on genetics, lipid metabolism, and their implications for cardiovascular health. It discusses a case of a 59-year-old woman with unexpected heart issues despite having low calculated risk. The speaker explores why people with certain genetic predispositions may still suffer heart attacks despite seemingly low risk factors like cholesterol. The liver's role in cholesterol management and the significance of lipoprotein particles, especially Apolipoprotein A, are highlighted. Recent advancements in treatment, including new agents like bimpedoic acid, are discussed, emphasizing the need for personalized medicine and genetic consideration in treatment plans.

Asset Subtitle

David Zidar, MD, PhD, FSCAI

Keywords

genetics

lipid metabolism

cardiovascular health

lipoprotein particles

personalized medicine